Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma

Acta Pharm Sin B. 2023 May;13(5):1903-1918. doi: 10.1016/j.apsb.2022.08.009. Epub 2022 Aug 18.

Abstract

Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed "don't eat me" signals; these signals include sialic acid-binding immunoglobulin-type lectin-10 (Siglec-10) and the recently revealed CD24 immune checkpoint (ICP). In this study, we demonstrate that targeting a specific glycan on CD24 exhibits the potential to inhibit ICP. Sambucus nigra agglutinin (SNA), a sialic acid-binding lectin, was employed to block CD24 and to enhance phagocytosis in melanoma tumours. In addition, we prepared SNA-conjugated hollow gold-iron oxide nanoparticles for photothermal therapy of tumours. Our findings show that the combination treatment of SNA-conjugated photothermal nanoparticles and near-infrared exposure successfully augments tumour cell phagocytosis both in vitro and in vivo models.

Keywords: Glycan; Immune checkpoint; Immunotherapy; Lectin; Macrophages; Melanoma cancer; Phagocytosis; Photothermal nanoparticles.